---
$id: https://graph.org.ai/products/commodity/51111840
$type: Product
source: UNSPSC
code: "51111840"
title: "Cetrorelix"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cetrorelix

**UNSPSC Code**: 51111840
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a gonadotropin releasing hormone inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OON1HFZ4BA. European Medicines Agency schedules Cetrorelix in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07459MIG. Cetrorelix generally arises in the molecular formula C70H92CLN17O14. The term CETRORELIX is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, no. 3 1991, list 31.) CETRORELIX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cetrorelix under HS 29371900 and SITC 54154. As of Q4 2014, CETRORELIX remains the US FDA Preferred Term for this commodity. Cetrorelix bears US NLM identifiers UMLS ID C0209366 and NCI Concept Code C2481. SMILES: CLC1CCC(CC(NC(=O)C(NC(=O)C)CC2CC3C(CC2)CCCC3)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C(CCC2)C(=O)NC(C)C(=O)N)CCCNC(=N)N)CC(C)C)CCCNC(=O)N)CC2CCC(O)CC2)CO)CC2CCCNC2)CC1.

